Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

RCn: a new class of micellar antitumor drugs with specific affinity for tumor cells membranes and ability to behave as nanocarriers for other bioactive molecules


Detailed Technology Description

Recentgenerations of anti-cancer therapies provide more effective treatment withreduction of toxicity by two approaches: the use of a new drug with specifictumor-targeting properties, and the use of drug-loaded nanosized carriers. RCn moleculesrepresent a novel class of compounds that demonstrate effective anti-tumorproperties and limited toxicity as both a tumor-targeting drug and a micellecarrier.


Countries

Not Available


Application No.

None


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View